Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sage Therapeutics Inc. buy melinda

Start price
€56.56
19.09.17 / 50%
Target price
€78.47
09.11.17
Performance (%)
46.88%
End price
€83.08
09.11.17
Summary
This prediction ended on 09.11.17 with a price of €83.08. With a performance of 46.88% the BUY prediction by melinda was a big success. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Sage Therapeutics Inc. -0.090% -0.090% -77.561% -81.955%
iShares Core DAX® 0.051% 5.593% 14.403% 19.767%
iShares Nasdaq 100 1.808% 7.445% 34.917% 57.237%
iShares Nikkei 225® 2.181% 2.815% 11.116% 8.873%
iShares S&P 500 1.040% 4.975% 27.631% 48.786%

According to melinda what are the pros and cons of Sage Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Sage Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 46.88%
Target price 78.474
Change
Ends at 09.11.17

Für pharmazeutische Werten ist die Washington Schweigen ist Gold



SAGE Therapeutics Inc: Technische Analyse-Diagramm SAGE Therapeutics Inc. | SAGE | US78667J1088 | Gemeinschaft Zone


Prediction Buy
Perf. (%) 46.88%
Target price 78.474
Change
Ends at 09.11.17

(Zielkurs erreicht)

Stopped prediction by melinda for Sage Therapeutics Inc.

buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€37.99
27.12.21
€42.00
27.12.22
-5.05%
28.12.22

Could be worthwhile Investment >10% per year
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€47.92
19.06.21
€58.00
19.06.22
-20.72%
27.12.21

Could be worthwhile Investment >10% per year
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€117.61
11.11.18
€153.34
22.01.19
3.72%
22.01.19

Could be worthwhile Investment >10% per year
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€62.71
19.09.17
€87.00
09.11.17
46.88%
09.11.17

Could be worthwhile Investment >10% per year
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€41.96
12.07.16
€44.20
10.11.16
7.26%
10.11.16

Could be worthwhile Investment >10% per year